Evidence map›Paper›PMID 26067254›Full record

ArticlePLoS pathogens2015

Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels.

Soeren Ocvirk, Irina G Sava, Isabella Lengfelder, Ilias Lagkouvardos, Natalie Steck, Jung H Roh, Sandrine Tchaptchet, Yinyin Bao, Jonathan J Hansen, Johannes Huebner and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. mBio · 2026
    Article
  2. Biofilm dispersion inbioRxiv : the preprint server for biology · 2026
    Article
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Microbiology and molecular biology reviews : MMBR · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Pathogenicity of Enterococci.Microbiology spectrum · 2019
    Review
  18. Article
  19. Loss of a Major Enterococcal Polysaccharide Antigen (Epa) byAntimicrobial agents and chemotherapy · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Soeren OcvirkTechnische Universität München, Chair of Nutrition and Immunology, ZIEL-Research Center for Nutrition and Food Sciences, Freising-Weihenstephan, Germany.
Irina G SavaTechnische Universität München, Chair of Nutrition and Immunology, ZIEL-Research Center for Nutrition and Food Sciences, Freising-Weihenstephan, Germany.
Isabella LengfelderTechnische Universität München, Chair of Nutrition and Immunology, ZIEL-Research Center for Nutrition and Food Sciences, Freising-Weihenstephan, Germany.
Ilias LagkouvardosTechnische Universität München, Chair of Nutrition and Immunology, ZIEL-Research Center for Nutrition and Food Sciences, Freising-Weihenstephan, Germany.
Natalie SteckTechnische Universität München, Chair of Nutrition and Immunology, ZIEL-Research Center for Nutrition and Food Sciences, Freising-Weihenstephan, Germany.
Jung H RohDivision of Infectious Diseases, Department of Internal Medicine, The University of Texas Medical School, Houston, Texas, United States of America.
Sandrine TchaptchetDivision of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Yinyin BaoDivision of Infectious Diseases, Department of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Jonathan J HansenDivision of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Johannes HuebnerDivision of Infectious Diseases, Department of Medicine, University Medical Center Freiburg, Freiburg, Germany.
Ian M CarrollDivision of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Barbara E MurrayDivision of Infectious Diseases, Department of Internal Medicine, The University of Texas Medical School, Houston, Texas, United States of America.
R Balfour SartorDivision of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Dirk HallerTechnische Universität München, Chair of Nutrition and Immunology, ZIEL-Research Center for Nutrition and Food Sciences, Freising-Weihenstephan, Germany.
University of North Carolina at Chapel Hill · USThe University of Texas at Austin · USUniversity Medical Center Freiburg · DE

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
National Gnotobiotic Rodent Resource CenterP40OD010995 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ryan B Sartor · 2012 to 2026
$9.7M
Alternative Approaches for E. faecalis InfectionsR01AI047923 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, BARBARA E · 2010 to 2014
$3.1M
NCATS NIH HHS UL1 TR000448NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1RR024992NIAID NIH HHS R01 AI047923NIAID NIH HHS R01 AI 47923NIDDK NIH HHS 5-P39-DK034987NIDDK NIH HHS P30 DK034987NIH HHS 5-P40-OD010995NIH HHS P40 OD010995
6 · The paper itself

Abstract

The commensal Enterococcus faecalis is among the most common causes of nosocomial infections. Recent findings regarding increased abundance of enterococci in the intestinal microbiota of patients with inflammatory bowel diseases and induction of colitis in IL-10-deficient (IL-10-/-) mice put a new perspective on the contribution of E. faecalis to chronic intestinal inflammation. Based on the expression of virulence-related genes in the inflammatory milieu of IL-10-/- mice using RNA-sequencing analysis, we characterized the colitogenic role of two bacterial structures that substantially impact on E. faecalis virulence by different mechanisms: the enterococcal polysaccharide antigen and cell surface-associated lipoproteins. Germ-free wild type and IL-10-/- mice were monoassociated with E. faecalis wild type OG1RF or the respective isogenic mutants for 16 weeks. Intestinal tissue and mesenteric lymph nodes (MLN) were collected to characterize tissue pathology, loss of intestinal barrier function, bacterial adhesion to intestinal epithelium and immune cell activation. Bone marrow-derived dendritic cells (BMDC) were stimulated with bacterial lysates and E. faecalis virulence was additionally investigated in three invertebrate models. Colitogenic activity of wild type E. faecalis (OG1RF score: 7.2±1.2) in monoassociated IL-10-/- mice was partially impaired in E. faecalis lacking enterococcal polysaccharide antigen (ΔepaB score: 4.7±2.3; p<0.05) and was almost completely abrogated in E. faecalis deficient for lipoproteins (Δlgt score: 2.3±2.3; p<0.0001). Consistently both E. faecalis mutants showed significantly impaired virulence in Galleria mellonella and Caenorhabditis elegans. Loss of E-cadherin in the epithelium was shown for all bacterial strains in inflamed IL-10-/- but not wild type mice. Inactivation of epaB in E. faecalis reduced microcolony and biofilm formation in vitro, altered bacterial adhesion to intestinal epithelium of germ-free Manduca sexta larvae and impaired penetration into the colonic mucus layer of IL-10-/- mice. Lipoprotein-deficient E. faecalis exhibited an impaired TLR2-mediated activation of BMDCs in vitro despite their ability to fully reactivate MLN cells as well as MLN-derived colitogenic T cells ex vivo. E. faecalis virulence factors accounting for bacterial adhesion to mucosal surfaces as well as intestinal barrier disruption partially contribute to colitogenic activity of E. faecalis. Beyond their well-known role in infections, cell surface-associated lipoproteins are essential structures for colitogenic activity of E. faecalis by mediating innate immune cell activation.

Indexed as

AnimalsBlotting, WesternColitisEnterococcus faecalisFluorescent Antibody TechniqueGram-Positive Bacterial InfectionsIn Situ Hybridization, FluorescenceInterleukin-10LipoproteinsMiceMice, KnockoutVirulenceIL10 protein, mouseInterleukin-10Lipoproteins

Identifiers

PMID26067254
PMCPMC4466351
OpenAlexW593945491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.